- Home
- MAPS vs ENTA Comparison
MAPS vs ENTA Comparison
Compare MAPS & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAPS
- ENTA
- Stock Information
- Founded
- MAPS 2008
- ENTA 1995
- Country
- MAPS United States
- ENTA United States
- Employees
- MAPS N/A
- ENTA N/A
- Industry
- MAPS Computer Software: Prepackaged Software
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- MAPS Technology
- ENTA Health Care
- Exchange
- MAPS Nasdaq
- ENTA Nasdaq
- Market Cap
- MAPS 119.8M
- ENTA 127.8M
- IPO Year
- MAPS N/A
- ENTA 2013
- Fundamental
- Price
- MAPS $1.22
- ENTA $6.13
- Analyst Decision
- MAPS Buy
- ENTA Buy
- Analyst Count
- MAPS 2
- ENTA 4
- Target Price
- MAPS $2.61
- ENTA $19.50
- AVG Volume (30 Days)
- MAPS 1.0M
- ENTA 464.3K
- Earning Date
- MAPS 11-12-2024
- ENTA 02-05-2025
- Dividend Yield
- MAPS N/A
- ENTA N/A
- EPS Growth
- MAPS N/A
- ENTA N/A
- EPS
- MAPS N/A
- ENTA N/A
- Revenue
- MAPS $183,311,000.00
- ENTA $67,635,000.00
- Revenue This Year
- MAPS N/A
- ENTA $11.80
- Revenue Next Year
- MAPS $9.09
- ENTA $3.99
- P/E Ratio
- MAPS N/A
- ENTA N/A
- Revenue Growth
- MAPS N/A
- ENTA N/A
- 52 Week Low
- MAPS $0.70
- ENTA $5.84
- 52 Week High
- MAPS $1.49
- ENTA $17.80
- Technical
- Relative Strength Index (RSI)
- MAPS 52.06
- ENTA 25.78
- Support Level
- MAPS $1.07
- ENTA $5.84
- Resistance Level
- MAPS $1.49
- ENTA $6.56
- Average True Range (ATR)
- MAPS 0.13
- ENTA 0.78
- MACD
- MAPS -0.03
- ENTA -0.19
- Stochastic Oscillator
- MAPS 35.71
- ENTA 7.73
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on our marketplace ads.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.